✦ LIBER ✦

Phase II Study of Single Agent Paclitaxel in Adult Patients with Relapsed Acute Lymphocytic Leukemia

✍ Scribed by Dawn E. Colburn; Deborah A. Thomas; Francis J. Giles

Book ID: 110430260
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 49 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1022984830258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of sphingosomal vincristi

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

✍ Deborah A. Thomas; Andreas H. Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Phase I/II Trial of Nanomolecular Liposo

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

✍ Wetzler, Meir; Thomas, Debora A.; Wang, Eunice S.; Shepard, Robert; Ford, Laurie 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 126 KB

A phase II study of single agent paclita

A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer

✍ N.G. Davidson; J.B. Chick; T.J. Perren; N. Campbell; J.M. Thompson; Y.T.S. Chan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Phase II study of single-agent bortezomi

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

✍ Stefan Faderl; Kanti Rai; John Gribben; John C. Byrd; Ian W. Flinn; Susan O'Brie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Phase II study of nilotinib in patients

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

✍ Ottmann, O G; Larson, R A; Kantarjian, H M; le Coutre, P D; Baccarani, M; Hochha 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB